Fitness to Practise Cases
This archive contains General Pharmaceutical Council (GPhC) Fitness to Practise (FtP) case summaries, detailing regulatory decisions affecting pharmacy professionals in the UK.
Each case provides insight into professional misconduct, errors, and ethical breaches that led to sanctions such as suspension, removal, or warnings. These summaries are valuable for:
- Pharmacists & Pharmacy Technicians – to understand common regulatory pitfalls.
- Employers & HR Teams – to learn about professional accountability and compliance.
- Pharmacy Students – to prepare for real-world ethical challenges in pharmacy practice.
Why it matters:
The decisions in these cases shape the legal and ethical landscape of pharmacy practice. Staying informed can help pharmacy professionals avoid similar mistakes and maintain high professional standards.
Use the form below to search for and filter cases that match your interests
Page 36 of 54
Pharmacy Technician Suspended for Three Months Following Forgery to Obtain NPA Qualification
The registrant, a newly qualified pharmacy technician, enrolled on the National Pharmacy Association’s Accuracy Checking Technician (ACT) course in 2017. To pass the course, candidates must submit a portfolio with evidence of 1,000 accuracy checks and regular appraisals by a supervising pharmacist. She submitted her ACT portfolio in October 2017, but: After initially denying the […]
31 March 2025
Lloydspharmacy Pharmacist Issued Warning for Dispensing Error, Data Misuse, and Improper Staffing Practices
The General Pharmaceutical Council (GPhC) investigated the registrant after Lloyds Pharmacy (now McKesson UK) raised concerns regarding two separate incidents involving professional misconduct. 1. Dispensing Error and Data Misuse On 5 February 2022, the registrant made a dispensing error involving Physeptone 1mg/ml oral solution (a Schedule 2 Controlled Drug). Instead of following proper procedures: 2. […]
29 March 2025
Pharmacist Issued Warning for Failing to Ensure Safe Online Dispensing Practices
Between September and November 2021, the registrant, acting as both Superintendent and Responsible Pharmacist, entered into a third-party dispensing arrangement with an online pharmacy. The GPhC found that: Despite being responsible for the safe management of the pharmacy service, the registrant failed to conduct due diligence before entering into the partnership, and did not establish […]
28 March 2025
Rowlands Pharmacist Issued Warning for Falsifying Controlled Drug Records and Failing to Maintain Governance
The General Pharmaceutical Council (GPhC) reviewed the conduct of the registrant, who worked as a Responsible Pharmacist at a Rowlands Pharmacy branch. Following the merger of two pharmacy branches, the registrant was responsible for maintaining governance, particularly around Controlled Drug (CD) management and error monitoring. However, the GPhC found that the registrant: Findings The GPhC […]
23 March 2025
Pharmacist Issued Warning After High-Risk Dispensing Error involving Methotrexate and Dexamethasone
On 11 May 2023, the registrant was working as the Responsible Pharmacist and failed to correctly check a prescription intended for Patient A. The prescription was for Dexamethasone 2mg daily, but Methotrexate 2.5mg daily—a high-risk immunosuppressant—was dispensed in error. Despite the medication box displaying clear warnings and significant differences in dose and frequency, the registrant: […]
22 March 2025
Pharmacy Technician Issued Warning for Failing to Escalate High-Risk Medication Concerns
The General Pharmaceutical Council (GPhC) Investigating Committee reviewed the conduct of the registrant between June 2022 and March 2023, during which concerns were raised regarding patient safety risks linked to high-risk medication handling. At the time, the registrant’s role involved: However, the GPhC found that the registrant: Findings The committee determined that: A direct quote […]
20 March 2025
Pharmacist Suspended for Eight More Months Following Dishonesty in Prescription and Governance Matters
The General Pharmaceutical Council (GPhC) investigated the registrant following concerns about serious dishonesty and fraudulent activity in pharmacy governance. Between 2019 and 2021, while employed at multiple pharmacies, the registrant: A GPhC hearing in March 2024 found the registrant guilty of dishonesty and misconduct, leading to a 12-month suspension. The March 2025 review hearing assessed […]
19 March 2025
Pharmacist Cleared to Practise After Completing Remediation for Dishonesty Misconduct
The General Pharmaceutical Council (GPhC) investigated the registrant following allegations that they had misrepresented their work experience on both their CV and LinkedIn profile. At the original hearing in February 2023, the panel found that: The registrant was suspended for 12 months, with a review hearing scheduled to assess progress on remediation and insight. Findings […]
12 March 2025
Pharmacist Placed Under Conditions Following Repeated Governance Failures in Codeine Linctus Supply
The General Pharmaceutical Council (GPhC) reviewed the registrant’s fitness to practise following a history of regulatory breaches related to the supply of codeine linctus, a pharmacy-only medicine known to be misused for its opioid effects. Concerns were first raised in 2020, when the Medicines and Healthcare products Regulatory Agency (MHRA) flagged unusually high purchasing patterns […]
11 March 2025
Pharmacist Removed from Register Following Caution for Offering to Supply Controlled Drugs
The General Pharmaceutical Council (GPhC) investigated the registrant following a police investigation into allegations that they had offered to supply controlled drugs to a vulnerable individual with a known dependency on prescription medication. The matter was reported to Dorset Police on 1 March 2021, and evidence obtained from mobile phone messages indicated that the registrant […]
10 March 2025